Prof. Maria Cecilia Giron Awarded for Her Scientific Contribution on Cancer Therapy and Microbiota

Prof. Giron presented a strategic talk on "Cancer Therapy and Microbiota" on which she was discerned the Best Scientific Contribution Award during Trageting Microbiota 2022. 

Prof. Maria Cecilia Giron gave an overview of the influence of gut microbiota on ensuring the efficacy and lowering the toxicity of current cancer therapies. She is Associate Professor of Pharmacology at the University of Padova where together with her team is focused in targeting the interaction between innate immunity, enteric nervous system and microbiome in diverse intestinal inflammatory pathologies (e.g., Irritable Bowel Syndrome (IBS), Inflammatory Bowel Diseases (IBD) and Inflammation-Associated Colorectal Cancers) as well as in gut neuropathies including Multiple Sclerosis and Parkinson’s Disease in order to develop new pharmacological treatments and/or nutritional strategies.

Dr. Giron currently serves as pharmacologist in the Ethics Committee for Clinical Studies of the Padova University Hospital, in the Ethics Committee for Oncological Clinical Trials of the Veneto Institute of Oncology and in the Veneto Region Medicines Evaluation Committee. She is a pioneer in research on the role of gut microbiota and intestinal function in normal and pathological conditions. She is author of more than 60 peer-reviewed publications, and co-founder of Eubiome, an innovative University spin-off and start-up, involved in FMT research and therapeutic applications of gut microbiota in human and animal recipients.

The International Society of Microbiota allows you to access the full conference on demand.

Prof. Maria Cecilia Giron's Presentation